No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].

Saved in:
Bibliographic Details
Title: No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
Authors: Buckley AJ; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates. abuckley@icldc.ae., Tan GD; OCDEM, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford, UK., Gruszka-Goh M; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK., Scanlon PH; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK., Ansari I; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates., Suliman SGI; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.
Source: Diabetologia [Diabetologia] 2025 Dec; Vol. 68 (12), pp. 2925-2927. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Letter
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41051410
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Buckley+AJ%22">Buckley AJ</searchLink>; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates. abuckley@icldc.ae.<br /><searchLink fieldCode="AU" term="%22Tan+GD%22">Tan GD</searchLink>; OCDEM, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gruszka-Goh+M%22">Gruszka-Goh M</searchLink>; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.<br /><searchLink fieldCode="AU" term="%22Scanlon+PH%22">Scanlon PH</searchLink>; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.<br /><searchLink fieldCode="AU" term="%22Ansari+I%22">Ansari I</searchLink>; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Suliman+SGI%22">Suliman SGI</searchLink>; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220006777%22">Diabetologia</searchLink> [Diabetologia] 2025 Dec; Vol. 68 (12), pp. 2925-2927. <i>Date of Electronic Publication: </i>2025 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>0006777 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0428 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220012186X%22">0012186X </searchLink><i>NLM ISO Abbreviation: </i>Diabetologia <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41051410
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00125-025-06562-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2925
    Titles:
      – TitleFull: No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Buckley AJ
      – PersonEntity:
          Name:
            NameFull: Tan GD
      – PersonEntity:
          Name:
            NameFull: Gruszka-Goh M
      – PersonEntity:
          Name:
            NameFull: Scanlon PH
      – PersonEntity:
          Name:
            NameFull: Ansari I
      – PersonEntity:
          Name:
            NameFull: Suliman SGI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0428
          Numbering:
            – Type: volume
              Value: 68
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Diabetologia
              Type: main
ResultId 1